GPR55
GPR55 is a G protein-coupled receptor that is encoded by the GPR55 gene in humans. It is considered to be a part of the endocannabinoid system, although its role and function are still under investigation.
Function[edit]
GPR55 is a receptor that has been implicated in various physiological processes. It is activated by lysophosphatidylinositol (LPI) and has been suggested to play a role in pain perception, bone physiology, and cancer.
Endocannabinoid System[edit]
While GPR55 is often associated with the endocannabinoid system, it does not bind to cannabinoids in the same way as the classical cannabinoid receptors CB1 and CB2. Instead, it is activated by LPI, a lipid that is structurally distinct from cannabinoids.
Clinical Significance[edit]
Research into GPR55 is ongoing, with studies exploring its potential as a therapeutic target. It has been linked to various conditions, including inflammatory diseases, neuropathic pain, and osteoporosis.
Cancer Research[edit]
GPR55 has been studied in the context of cancer, where it may influence tumor growth and metastasis. Some studies suggest that GPR55 activation can promote cancer cell proliferation, making it a potential target for anticancer therapies.
See Also[edit]
References[edit]
